Microdosing Tirzepatide for Weight Maintenance: Who It's For

You have reached your goal weight. The active weight loss phase is done, and now you are thinking about what comes next. If you have been on tirzepatide, you have probably wondered: can you stay on it at a lower dose, or do you need to stop completely?

The answer is more nuanced than yes or no. Tirzepatide microdosing, or staying on a significantly lower maintenance dose, is a clinical strategy that some providers use for patients who want to maintain their results. It is not an official FDA-approved indication, and there is no standardized protocol. But it is a real option worth discussing with your provider if you are interested in continuing medication at a lower cost and lower dose.

What “tirzepatide microdosing” actually means

Tirzepatide microdosing does not have a formal definition in medical literature. When providers and patients talk about it, they mean staying on tirzepatide at doses substantially lower than the ones used for active weight loss.

Active weight loss typically requires doses of 10mg to 15mg per week. Maintenance microdoses are often much lower: 1mg, 2.5mg, or 5mg per week. The exact dose depends on your individual response, your prior treatment history, and how much appetite control you need to maintain your current weight.

The key point: your provider is making this dosing decision based on clinical judgment, not from a textbook protocol. It is personalized to your situation.

Why lower doses might work for maintenance

Tirzepatide is a dual GLP-1 and GIP receptor agonist. This dual mechanism is part of what makes it effective for weight loss at higher doses. But the research suggests that both receptors contribute across a range of doses, not just at the high end.

Think of appetite signaling like a volume knob. At full volume (10-15mg per week), the appetite signal is turned way down, which supports active weight loss. At half-volume (2-5mg per week), the signal is turned down enough to reduce the constant urge to eat, but not so aggressively that you feel completely suppressed.

For someone who has already lost weight and built new eating habits, that lower-volume appetite reduction may be enough to maintain stability without the side effects or cost of a full weight-loss dose.

What the SURMOUNT-4 trial showed

The strongest evidence for why some people consider maintenance dosing comes from the SURMOUNT trial data. The SURMOUNT-4 trial, published in JAMA in 2024^[1], compared what happened to people who stopped tirzepatide versus those who continued it at maintenance doses.

The findings were striking: patients who stopped tirzepatide completely regained approximately 14% of the body weight they had lost over the following year. Patients who continued on maintenance doses maintained their results.

This tells you something important about what tirzepatide does. It is not just jumpstarting weight loss; it is actively managing appetite signals. When you stop the medication, that appetite regulation goes away, and for many people, the urge to eat returns to pre-treatment levels. The regain is not a sign of failure. It is a sign that the medication was doing a real job managing a biological process.

Why maintenance is different from stopping entirely

If you stop tirzepatide completely, you are left with your baseline appetite signals. For many people who started on GLP-1 or tirzepatide in the first place, those baseline signals are difficult to manage. The SURMOUNT-4 data shows that directly: significant weight regain within a year is common.

With a maintenance microdose, you are not eliminating appetite regulation; you are keeping it at a lower level. It is less aggressive than the active weight-loss dose, but it is still present.

The biology does not change when you go from 15mg to 5mg. The GLP-1 and GIP receptors are still getting activated, still reducing appetite, still slowing gastric emptying. You are just using a lower dose to achieve a less aggressive effect.

What microdosing looks like in practice

If your provider recommends a maintenance microdose, here is what that might look like:

You were on 15mg per week for active weight loss. Your provider discusses stepping down to 5mg per week for maintenance. You do this gradually, over a few weeks, monitoring how you feel and how your weight behaves.

At 5mg per week, you might find that your appetite is reduced but not suppressed. You feel normal hunger at meals, but you do not feel compelled to snack or think about food constantly throughout the day. Your weight stays stable.

The dose is adjusted based on your individual response. If 5mg is too much and you are losing weight when you want to maintain, you might go down to 2.5mg or even 1mg. If 5mg is not enough and you are starting to experience hunger creep, your provider might suggest stepping up to 7.5mg.

This is clinical judgment, not protocol. Your provider is making decisions based on your specific situation: your response to medication, your eating habits, your goals, and your health history.

The Transformation Health Microdose program

Transformation Health offers a Microdose program specifically for people at goal weight who want to stay on a maintenance dose. Here is what qualifies and what is included.

Who qualifies:

• Prior GLP-1 experience (you have completed at least one full cycle of weight loss medication)
• Current BMI of 20 or higher
• No contraindications to continued tirzepatide use (your provider will assess this)

What is included ($199 per month):

• Your compounded tirzepatide medication at your prescribed maintenance dose
• Provider check-ins to monitor your progress and adjust your dose as needed
• Lab work to ensure your health markers remain stable
• Medical weight loss coaching to support habit maintenance
• No hidden fees. No surprises at billing time.

The program is designed for people who have done the hard work of losing weight and want clinical support for the maintenance phase. It costs less than the standard tirzepatide program ($339 per month) because you are on a lower dose, but you still get the same level of provider oversight and support.

How to get evaluated

If you are interested in whether tirzepatide microdosing is right for you, here is the process:

1. Complete a free online assessment. You will answer questions about your health history, your prior experience with GLP-1 medications, your current weight, and your goals.
2. An independent, licensed provider reviews your assessment. They look at your history, your current health, and whether a maintenance dose is medically appropriate for your situation.
3. If your provider determines that you are a good candidate, you will have a consultation (by phone or video, depending on your state) to discuss your specific maintenance plan.
4. If you proceed, your medication is prepared by a licensed US compounding pharmacy and shipped to your door.
5. You start on your prescribed maintenance dose. Your provider checks in regularly to monitor your progress and adjust your dose if needed.

Residents of AR, DC, DE, MS, NM, RI, and WV are required by state law to complete a live video consultation before a prescription can be issued.

What happens if maintenance is not right for you

Microdosing is not the only path after reaching goal weight. Some people do better stopping medication entirely and maintaining through diet and exercise alone. Some people find that even a microdose is too much or not necessary. Some people stay on their active-weight-loss dose if they continue to have strong appetite signals.

Your provider will discuss what makes sense for your specific situation. The Microdose program is one option among several. The goal is to find what works for you long-term, not to push you into any particular approach.

Key takeaways

• Tirzepatide microdosing is not an FDA-approved indication, but it is a clinical strategy some providers use for maintenance after active weight loss.
• There is no official protocol. Your provider determines the right maintenance dose for your situation based on your response, goals, and health history.
• The SURMOUNT-4 trial showed that stopping tirzepatide entirely leads to significant weight regain for many people (approximately 14% over a year), while staying on a maintenance dose maintains results.
• Maintenance doses are typically 1mg to 5mg per week, well below the 10-15mg used for active weight loss.
• The Transformation Health Microdose program is $199 per month, all-inclusive, and is designed for people at goal weight with prior GLP-1 experience.
• Your provider makes the decision about whether maintenance dosing is appropriate for you based on your individual health history and goals.

What to read next

Learn more about the full path after reaching goal weight by reading GLP-1 Microdosing and Maintenance. If you are thinking about stopping medication entirely, Stopping Weight Loss Medication: What Happens walks through the trial data and what to expect.

For more details on how compounded tirzepatide works and what it includes at our standard dose, see Compounded Tirzepatide: What It Is and How It Works.

Citations

[1] Aronne LJ, et al. “Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.” JAMA. 2024;331(1):38-48. https://pubmed.ncbi.nlm.nih.gov/38078870/